| Name | ethyl 4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoate |
|---|---|
| Synonyms |
N-(4-(Ethoxycarbonyl)phenyl)retinamide
viaminate 4-(Ethoxycarbophenyl)retinamide 4-(Carboethoxyphenyl)retinamide retinamide ethyl benzoate Retinamide,N-(4-(ethoxycarbonyl)phenyl) |
| Description | Viaminate is a derivative of Retinoic acid, which is used for the treatment of severe acne and other keratinization disorders. |
|---|---|
| Related Catalog | |
| In Vitro | Viaminate is an amide compound formed by Tretinoin and Ethyl p-aminobenzoate, in which the end group of Tretinoin is transformed into amide and ester chain[1]. |
| References |
[1]. Zhang H, et al. Fatal Hepatotoxicity Due to Viaminate. Am J Med Sci. 2018 Jul;356(1):84-86. |
| Density | 1.071 g/cm3 |
|---|---|
| Boiling Point | 619.4ºCat 760 mmHg |
| Melting Point | 177-182 °C |
| Molecular Formula | C29H37NO3 |
| Molecular Weight | 447.61 |
| Flash Point | 328.4ºC |
| Exact Mass | 447.27700 |
| PSA | 55.40000 |
| LogP | 7.40640 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xi |
|---|